Binding Site’s Immunologicals Group is able to provide ethically sourced serum and/or plasma biological materials from a variety of infectious disease state conditions

The study, published in Nature Biomedical Engineering, is led by the Politecnico di Milano alongside the University Hospital of Basel and the University Hospital of Zurich

Two 1.2 GHz superconducting magnets have now reached full field at Bruker’s Swiss magnet factory

Available in a choice of 24-, 96-, and 384-well formats, Krystal (TM) series clear bottom assay plates are widely recognized as industry-leading cell culture tools by many pharma drug discovery and screening labs

Using an new optical technique, labs could mass-produce artificial tissues or organs at unprecedented speed

Potential for new drug to prevent colorectal cancer tumors

Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis

Existing approaches to testing potential treatments through drug screening do not take account of the fact that the genetic errors that cause kidney diseases vary from patient to patient

Microfluidic tech effectively shrinks a medical pathology laboratory onto a small chip

In mice, new compound lifts molecular ‘brakes’ that normally slow the regeneration of blood stem cells

Long, high-yield oligos with industry-beating low error rate enable researchers to skip amplification steps and start projects immediately

The drug, an experimental compound called PTC596, has a durable half-life and can evade a pump that many cancer cells use to expel drugs